Erythropoiesis inhibitory factor(s) from human plasma and urine: The production and application of a neutralizing anti-EIF serum

Frederick A. Garver, Willie A. Neal, Jasper P. Lewis, Hernan E. Grenett, Charles L. Lutcher, Takeshi Ozawa, Russell R Moores, Claude Starr Wright

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The erythropoiesis inhibitory fraction (EIF) isolated from different plasmas is equally effective on a weight basis. However, the yield of the plasma EIF fraction varies relative to the source. In general, the amounts of the inhibitor fraction seem to increase with, but not parallel to, increased erythropoiesis. A young girl with recessive erythrocytosis, and a renal transplant patient, however, have a relative deficiency of the EIF fraction which could explain the erythrocytosis.

Original languageEnglish (US)
Pages (from-to)174-185
Number of pages12
JournalBiochemical Medicine
Volume25
Issue number2
DOIs
StatePublished - Jan 1 1981

Fingerprint

Plasma (human)
Erythropoiesis
Urine
Plasmas
Polycythemia
Transplants
Serum
Kidney
Weights and Measures

ASJC Scopus subject areas

  • Biochemistry

Cite this

Garver, F. A., Neal, W. A., Lewis, J. P., Grenett, H. E., Lutcher, C. L., Ozawa, T., ... Wright, C. S. (1981). Erythropoiesis inhibitory factor(s) from human plasma and urine: The production and application of a neutralizing anti-EIF serum. Biochemical Medicine, 25(2), 174-185. https://doi.org/10.1016/0006-2944(81)90074-0

Erythropoiesis inhibitory factor(s) from human plasma and urine : The production and application of a neutralizing anti-EIF serum. / Garver, Frederick A.; Neal, Willie A.; Lewis, Jasper P.; Grenett, Hernan E.; Lutcher, Charles L.; Ozawa, Takeshi; Moores, Russell R; Wright, Claude Starr.

In: Biochemical Medicine, Vol. 25, No. 2, 01.01.1981, p. 174-185.

Research output: Contribution to journalArticle

Garver, FA, Neal, WA, Lewis, JP, Grenett, HE, Lutcher, CL, Ozawa, T, Moores, RR & Wright, CS 1981, 'Erythropoiesis inhibitory factor(s) from human plasma and urine: The production and application of a neutralizing anti-EIF serum', Biochemical Medicine, vol. 25, no. 2, pp. 174-185. https://doi.org/10.1016/0006-2944(81)90074-0
Garver, Frederick A. ; Neal, Willie A. ; Lewis, Jasper P. ; Grenett, Hernan E. ; Lutcher, Charles L. ; Ozawa, Takeshi ; Moores, Russell R ; Wright, Claude Starr. / Erythropoiesis inhibitory factor(s) from human plasma and urine : The production and application of a neutralizing anti-EIF serum. In: Biochemical Medicine. 1981 ; Vol. 25, No. 2. pp. 174-185.
@article{6492f67b814a48ce91dc83bc6ee18cb6,
title = "Erythropoiesis inhibitory factor(s) from human plasma and urine: The production and application of a neutralizing anti-EIF serum",
abstract = "The erythropoiesis inhibitory fraction (EIF) isolated from different plasmas is equally effective on a weight basis. However, the yield of the plasma EIF fraction varies relative to the source. In general, the amounts of the inhibitor fraction seem to increase with, but not parallel to, increased erythropoiesis. A young girl with recessive erythrocytosis, and a renal transplant patient, however, have a relative deficiency of the EIF fraction which could explain the erythrocytosis.",
author = "Garver, {Frederick A.} and Neal, {Willie A.} and Lewis, {Jasper P.} and Grenett, {Hernan E.} and Lutcher, {Charles L.} and Takeshi Ozawa and Moores, {Russell R} and Wright, {Claude Starr}",
year = "1981",
month = "1",
day = "1",
doi = "10.1016/0006-2944(81)90074-0",
language = "English (US)",
volume = "25",
pages = "174--185",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Erythropoiesis inhibitory factor(s) from human plasma and urine

T2 - The production and application of a neutralizing anti-EIF serum

AU - Garver, Frederick A.

AU - Neal, Willie A.

AU - Lewis, Jasper P.

AU - Grenett, Hernan E.

AU - Lutcher, Charles L.

AU - Ozawa, Takeshi

AU - Moores, Russell R

AU - Wright, Claude Starr

PY - 1981/1/1

Y1 - 1981/1/1

N2 - The erythropoiesis inhibitory fraction (EIF) isolated from different plasmas is equally effective on a weight basis. However, the yield of the plasma EIF fraction varies relative to the source. In general, the amounts of the inhibitor fraction seem to increase with, but not parallel to, increased erythropoiesis. A young girl with recessive erythrocytosis, and a renal transplant patient, however, have a relative deficiency of the EIF fraction which could explain the erythrocytosis.

AB - The erythropoiesis inhibitory fraction (EIF) isolated from different plasmas is equally effective on a weight basis. However, the yield of the plasma EIF fraction varies relative to the source. In general, the amounts of the inhibitor fraction seem to increase with, but not parallel to, increased erythropoiesis. A young girl with recessive erythrocytosis, and a renal transplant patient, however, have a relative deficiency of the EIF fraction which could explain the erythrocytosis.

UR - http://www.scopus.com/inward/record.url?scp=0019455975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019455975&partnerID=8YFLogxK

U2 - 10.1016/0006-2944(81)90074-0

DO - 10.1016/0006-2944(81)90074-0

M3 - Article

C2 - 7283992

AN - SCOPUS:0019455975

VL - 25

SP - 174

EP - 185

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -